Skip to main content
Inify Laboratories AB logo

Inify Laboratories AB — Investor Relations & Filings

Ticker · INIFY ISIN · SE0017486103 LEI · 549300306YYJ3BX3VB98 ST Human health and social work activities
Filings indexed 339 across all filing types
Latest filing 2025-12-16 Director's Dealing
Country SE Sweden
Listing ST INIFY

About Inify Laboratories AB

https://www.inify.com/

Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. The company utilizes a fully digital, standardized, and AI-supported workflow for histopathology analysis. This integrated service model is designed to optimize the entire diagnostic process, from sample receipt to final report, ensuring high quality and significantly reduced turnaround times for clinical partners. Initially focused on prostate cancer, the company has expanded its diagnostic capabilities to include other areas such as gastroenterology. By streamlining the clinical pathway, Inify Laboratories enables healthcare providers to receive faster results, which facilitates earlier patient follow-up and treatment planning.

Recent filings

Filing Released Lang Actions
Inify Laboratories - notification of trade
Director's Dealing Classification · 100% confidence The document is a notification of a share transaction by a primary insider (CEO Fredrik Palm). It explicitly mentions the acquisition of 12,000 shares and cites the EU Market Abuse Regulation (MAR) article 19, which governs the disclosure of transactions by persons discharging managerial responsibilities. This fits the definition of a Director's Dealing (DIRS) filing.
2025-12-16 English
Inify Laboratories - notification of trade - Attachment: Notification_of_trade_2025_12_16.pdf
Director's Dealing Classification · 100% confidence The document is a notification of a share transaction by a primary insider (CEO Fredrik Palm). It explicitly mentions the acquisition of 12,000 shares and cites the EU Market Abuse Regulation (MAR) article 19, which governs the disclosure of transactions by persons discharging managerial responsibilities. This fits the definition of a Director's Dealing (DIRS) filing.
2025-12-16 English
Inify Laboratories - notification of trade
Director's Dealing Classification · 100% confidence The document is a notification of a share transaction by a primary insider (CEO Fredrik Palm) of Inify Laboratories. It explicitly details the acquisition of 12,000 shares, the price per share, and the updated total holdings of the insider. This aligns perfectly with the definition of a Director's Dealing (DIRS) filing, which covers personal share transactions by company executives.
2025-12-16 English
Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed repair issue - Attachment: Inify_Laboratories_appl_periods_private_placement_and_repair_iss
Capital/Financing Update Classification · 100% confidence The document is a press release from Inify Laboratories announcing the application periods for a private placement and a repair issue of shares. It details the subscription price, the timeline for the application periods, record dates, and settlement procedures. This document is a direct announcement of a capital-raising activity (share issuance) rather than a report itself, fitting the definition of a Capital/Financing Update.
2025-12-09 English
Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed repair issue
Capital/Financing Update Classification · 100% confidence The document is a press release from Inify Laboratories announcing the application periods for a private placement and a repair issue of shares. It details the subscription process, key dates, and regulatory disclosures related to these capital-raising activities. This falls under the category of capital and financing updates.
2025-12-09 English
Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed repair issue
Capital/Financing Update Classification · 100% confidence The document is a press release from Inify Laboratories announcing the application periods for a private placement and a repair issue of shares. It details the subscription price, the timeline for the application periods, record dates, and settlement procedures. This document is a direct announcement of a capital-raising activity (share issuance) rather than a report itself, fitting the definition of a Capital/Financing Update.
2025-12-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.